Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Bob Swift who wrote (2225)	4/2/1999 11:33:00 AM
From: quidditch	Read Replies (1) \| Respond to of 10280

Bob: I don't disagree. But, typically, the purposes for which the s/h authorization is sought are very broad to afford the B/D the maximum flexibility. To reference a financing does not necessarily mean that a financing is now contemplated. If SEPR did effect a 2 for 1 (as opposed to a 3 for 1, which is, of course, possible), they would have ample additional authorized but unissued capital stock for other purposes, e.g., expansion of employee stock option plan, acquisitions, etc. regards. Liacos_samui